(2006), 4.6 million people throughout the world are diagnosed with dementia every year, and the number of people in Europe suffering from dementia will increase to 13 million in 2040; and Wimo et al. (2003) estimates that approximately 63 million worldwide will suffer from this illness by 2030. This has crucial implications since it is an illness that is associated with long-term care (LTC). However, while LTC is an important consideration, the quality of life and how people with dementia cope with the illness are also of much concern, but less dealt into. Dementia can undermine a person’s self-worth and esteem, and affects most aspects of daily living (Preston, Marshall, & Bucks, 2007) affecting one’s quality of life (QOL).
(2006), 4.6 million people throughout the world are diagnosed with dementia every year, and the number of people in Europe suffering from dementia will increase to 13 million in 2040; and Wimo et al. (2003) estimates that approximately 63 million worldwide will suffer from this illness by 2030. This has crucial implications since it is an illness that is often associated with long-term care (LTC) in its later stages. However, while long-term care is an important consideration, the quality of life and how people with dementia cope with the illness are also of much concern but unfortunately less dealt into. Dementia can undermine a person’s self-worth and esteem, and affects most aspects of daily living (Preston, Marshall, & Bucks, 2007) affecting one’s quality of life (QOF).
Alzheimer’s disease affects as many as 4 million Americans. It can affect almost any age but still is more common in the ederly. As ageing population continues to increase, so does the disease. Today, 3% of the people ages 65 to 75 have alzheimer’s, 10% of those aged 75 to 85 have alzheimer’s and half the age 85 may have it to. Without a new cure it is estimated that alzheimers will affect over 14 million people by 2050.
Alzheimer's Disease Alzheimer’s Disease (AD) is a progressive degenerative disease of unknown aetiology, as first described by Alois Alzheimer (1907). According to Shoenberg et. al (1987), it is the commonest cause of dementia in the elderly with an incidence ranging from 2.5 to 5 per thousand. Furthermore, this incidence has grown in recent years as a result people generally living longer. The disease is incurable at present but there are drug treatments that delay the symptoms in the early stages.
Alzheimer’s Disease Alzheimer’s disease is a progressive condition where the neurons degenerate in the brain, while the brain substance shrinks in volume. Alzheimer’s is also the number one cause of dementia. When it was first noticed, Alzheimer’s was thought to be a pre-senile disease, but now it is known to be responsible for seventy-five percent of the dementia cases in people over sixty-five years of age. Alzheimer’s disease usually causes several years of personal and intellectual decline until death. Because there is an increasing number of elderly citizens in the United States, research into the causes and possible cures for the disease is on the rise (1).
Genetics is a key influence in developing Alzheimer’s, and as our population gets older, the disease impacts a greater percentage of Americans. Alzheimer’s or AD is a disease that can be lead to very severe problems and damage in the brain. Also, there is numerous studies taken place regarding the progressiveness of Alzheimer’s disease. Age and Genetics are primary risk factors for people that acquire Alzheimer’s disease. One in ten people over the age of 65, and over half of those over 85 have Alzheimer’s disease.
Pathology and Current Treatment of the Alzheimer's Disease Introduction One of the most feared aspects of aging is the deterioration of the memory and cognitive function (dementia) that occurs among the elderly with increasing frequency with advancing years. A significant proportion of otherwise healthy elderly persons show a significant decline in mental function later in life. It has been estimated that 10% of the population over the age of 65 suffers from mild to moderate dementia and 4-5% suffer from severe dementia. The incidence of severe dementia rises from less than 1% at ages 65 to 70 to over 15% by age 85 (Terry and Katzman, 1983). In the United States alone, Alzheimer’s disease (AD), which is the major cause of senile dementia, afflicts several million people, and with the increasing longevity of the population, the number of such patients requiring complete and continuous institutional care will rise to epidemic proportions.
Over the past three decades, mortality rate from Alzheimer's disease (AD) has steadily increased. Alzheimer's disease is one of the fastest developing disease and the sixth leading cause of death in the United States. This disease usually occurs in elderly people above the age of 60. According to National Institute on Aging (NIA) (2010), more than 5 million Americans are suffering from Alzheimer’s disease. By 2050, this number is expected to get double due to the aging of the population in the United States.
Estimates vary, but experts suggest that as many as 5.1 million Americans may have Alzheimer’s disease. Alzheimer’s disease is the most common cause of dementia among older people. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities, to such an extent that it interferes with a person’s daily life and activities. Dementia ranges in severity from the mildest stage, when it is just beginning to affect a person’s functioning, to the most severe stage, when the person must de... ... middle of paper ... ...ng with the disease. With numbers this high, there are several important things that someone developing Alzheimer’s or the loved ones of someone with Alzheimer’s should be aware of.
Biol. Res., 1992, 379: 123-42. Silverman W. Alzheimer neuropathology in mentally retarded. Acta Neuropathol. Berl., 1993, 85(3):260-6.